Ran Nussbaum Insider Profile

Ran Nussbaum, Director at Kite Pharma Inc, holds 1.44M shares in Urogen Pharma (Ticker: URGN), holds 7.80M shares in Eloxx Pharmaceuticals (Ticker: ELOX), holds 1.23M shares in Keros Therapeutics (Ticker: KROS). Most recently, Ran Nussbaum Bought ― shares of Urogen Pharma on Feb 28, 2023 for an estimated value of 11.05K.
Ran Nussbaum

Ran Nussbaum
Kite Pharma Inc (KITE)

Ranked #4,292 out of 102,868 Corporate Insiders

Profitable Transactions

9 out of 17 Profitable Transactions

Average Return

Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

A breakdown of Ran Nussbaum's holdings

Insider Roles

Keros Therapeutics
Director, Ten Percent Owner
Eloxx Pharmaceuticals
Urogen Pharma
Roles that Ran Nussbaum holds in companies

Most Profitable Insider Trade

Keros Therapeutics
Rating:Informative Buy
Date:Apr 13, 2020 - Apr 13, 2021
The most profitable trade made by Ran Nussbaum

Ran Nussbaum's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kite Pharma Inc
Oct 05, 2017
Uninformative Sell
Jan 16, 2020
Uninformative Sell
Eloxx Pharmaceuticals
May 17, 2021
Informative Buy
Urogen Pharma
Feb 28, 2023
Informative Buy
Keros Therapeutics
Nov 19, 2020
Director, Ten Percent Owner
Informative Buy
Prevail Therapeutics
List of latest transactions for each holding click on a transaction to see Ran Nussbaum's performance on stock

Ran Nussbaum insider profile FAQ

What is the percentage of profitable transactions made by Ran Nussbaum?
The percentage of profitable transactions made by Ran Nussbaum is 53%.
    What is the average return per transaction made by Ran Nussbaum?
    The average return per transaction made by Ran Nussbaum is 30.00%.
      What stocks does Ran Nussbaum hold?
      Ran Nussbaum holds: KITE, ARQL, ELOX, URGN, KROS, PRVL stocks.
        What was Ran Nussbaum’s latest transaction?
        Ran Nussbaum latest transaction was an Informative Buy of $11.05K.
          What was Ran Nussbaum's most profitable transaction?
          Ran Nussbaum’s most profitable transaction was an Informative Buy of KROS stock on April 13, 2020. The return on the trade was 175.70%.
            What is Ran Nussbaum's role in Kite Pharma Inc?
            Ran Nussbaum's role in Kite Pharma Inc is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.